PMA device
Sculptra
Q-Med AB · Implant, Dermal, For Aesthetic Use (LMH, Class III) · First FDA decision Aug 3, 2004, newest Oct 9, 2024Aesthetic skin, fat and body contouring
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
18
PMA pathway
Device trials
42
Naming "Sculptra"
MAUDE reports
363
Brand "Sculptra", since 2015
PubMed studies
107
Mentioning "Sculptra"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sculptra
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 18 decisions filed under this name.
- SCULPTRAPMA supplement
P030050-S051 · Decided Oct 9, 2024 · 145 days after receipt · Normal 180 Day Track No User Fee
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
5 more FDA decisions with a free account
Older decisions: P030050-S028, P030050-S017, P030050-S016, P030050-S009, P030050-S008, P030050-S007, P030050-S005, P030050-S004, P030050-S003, P030050-S002, P030050-S001, P030050
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Sculptra", any status and sponsor, newest update first.
Erevna Innovations Inc.Academic, hospital or other
NCT07205744 · 50 participants · Start Aug 14, 2025 · Primary completion Jul 13, 2026
Device: Restylane SkinBoosters Vital · For: Aesthetic; Menopause; Post-menopause and 3 more
Sites: Montreal, Canada
41 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sculptra", and for the whole product code for context.
This brand
363 reports: 9 malfunction, 353 injury, 0 death
Whole product code LMH
16,542 reports: 1,388 malfunction, 15,105 injury, 12 death
Newest reports for this brand
- SculptraInjury
9710154-2026-00111 · Received Oct 22, 2026
Device type: Implant, Dermal, For Aesthetic Use (LMH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Foreign Body Reaction; Fibrosis
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sculptra"[tiab]. The summary above synthesizes these.
- Sculptra.
Munk B · Posit Aware · 2004Newspaper Article
- Sculptra (injectable poly-L-lactic acid).
Keni SP, Sidle DM · Facial Plast Surg Clin North Am · 2007Review
- Effectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles.
Fabi S, Hamilton T, LaTowsky B, et al. · J Drugs Dermatol · 2024Randomized Controlled Trial
- Sculptra: the new three-dimensional filler.
Sherman RN · Clin Plast Surg · 2006
- Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations.
Haddad A, Avelar L, Fabi SG, et al. · Aesthetic Plast Surg · 2025Review, Consensus Statement
- Sculptra: a stimulatory filler.
Lacombe V · Facial Plast Surg · 2009
- Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V vs. Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial.
Han WY, Kim HJ, Kwon R, et al. · Aesthetic Plast Surg · 2023Randomized Controlled Trial, Equivalence Trial
- Complications of collagen biostimulators in Brazil: Description of products, treatments, and evolution of 55 cases.
Ianhez M, de Goés E Silva Freire G, Sigrist RMS, et al. · J Cosmet Dermatol · 2024
- A morphological analysis of calcium hydroxylapatite and poly-l-lactic acid biostimulator particles.
McCarthy AD, Hartmann C, Durkin A, et al. · Skin Res Technol · 2024Comparative Study
- The Differences Between Sculptra and AestheFill Reconstitution Processes.
Lin JY, Peng X, Lin CY · Aesthetic Plast Surg · 2025Comparative Study, Letter
- Use of sculptra mark in esthetic rejuvenation.
Beer KR, Rendon MI · Semin Cutan Med Surg · 2006Review
- Sculptra use in HIV-associated lipodystrophy.
Dinman S · Plast Surg Nurs · 2008
Other devices of this type
Also filed under product code LMH.
- RADIESSE® Injectable ImplantMerz North America, Inc. · PMA 2026
- Belotero Balance Dermal FillerMerz North America, Inc. · PMA 2026
- Restylane Injectable GelQ-Med AB · PMA 2022
- Restylane® ContourQ-Med AB · PMA 2026
- Juvederm Voluma XCAllergan · PMA 2025
- Juvéderm Voluma XC, Vollure XC, Volbella XC, Volux XC, SkinviveAllergan · PMA 2026
- Restylane® Lyft with LidocaineQ-Med AB · PMA 2025
- Belotero Balance (+) Lidocaine Dermal FillerMerz North America, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.